Search

everythinglearnresearchcommunity

for

Search:↓

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A new compound was effective for imaging prostate cancer in rats.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Kolaviron and quercetin may help treat prostate issues.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Smaller finasteride particles increase effectiveness in treating hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Taking finasteride before surgery reduces blood loss in prostate procedures.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Dutasteride may help shrink prostate cancer tumors.

Finasteride reduces bleeding during prostate surgery.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.